Understand the source comparison
Research Peptides Legal 2026: Comparison of Compliance Frameworks
The table below contrasts federal baseline requirements with the most restrictive state-level frameworks currently enforced as of March 2026. Federal (FDA) 'For Research Use Only—Not for Human Consumption' on all containers and documentation IRB, IACUC, or equ
No winner is assigned.
This page preserves a source comparison for education. It does not add a rating, recommendation or clinical judgment.
- The table below contrasts federal baseline requirements with the most restrictive state-level frameworks currently enforced as of March 2026.
- Federal (FDA)
- 'For Research Use Only—Not for Human Consumption' on all containers and documentation
- IRB, IACUC, or equivalent oversight verification required
- None required
- Misbranding and off-label marketing claims
- Baseline standard—all suppliers must meet federal floor
- California
- Federal labeling + California-specific MSDS disclosure
- IRB/IACUC verification + California facility license confirmation
- Consumer-facing sales and therapeutic marketing
- Moderate—additional disclosure adds minimal burden
- Florida
- Federal labeling + controlled precursor classification for certain peptides
- IRB/IACUC verification + 48-hour chain-of-custody submission
- Supplier must register with Florida Board of Pharmacy
- Controlled precursor diversion
- High—registration requirement excludes many suppliers
- Texas
- Federal labeling
- Institutional accountability—purchasing entity retains records for 7 years
- Institutional misuse during facility inspections
- Moderate—compliance burden shifts to buyer, not supplier
- New York
- Federal labeling + quarterly aggregate reporting for high-volume suppliers
- IRB/IACUC verification
- Quarterly reporting required if >50 units shipped per quarter
- Unlicensed high-volume distribution
- Moderate—reporting threshold excludes most research labs
- Washington/Oregon
- Reciprocal IRB/IACUC recognition between states
- Consumer-facing sales
- Low—reciprocal framework reduces multi-state complexity